105 related articles for article (PubMed ID: 25464927)
1. Multi-analyte profiling of inflammatory mediators in COPD sputum--the effects of processing.
Pedersen F; Holz O; Lauer G; Quintini G; Kiwull-Schöne H; Kirsten AM; Magnussen H; Rabe KF; Goldmann T; Watz H
Cytokine; 2015 Feb; 71(2):401-4. PubMed ID: 25464927
[TBL] [Abstract][Full Text] [Related]
2. The effect of dithiothreitol on chemotactic factors in induced sputum of chronic obstructive pulmonary disease patients.
Wang F; He B
Respiration; 2009; 78(2):217-22. PubMed ID: 19439918
[TBL] [Abstract][Full Text] [Related]
3. Effect of sputum processing with dithiothreitol on the detection of inflammatory mediators in chronic bronchitis and bronchiectasis.
Woolhouse IS; Bayley DL; Stockley RA
Thorax; 2002 Aug; 57(8):667-71. PubMed ID: 12149524
[TBL] [Abstract][Full Text] [Related]
4. Sputum biomarker profiles in cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) and association between pulmonary function.
Eickmeier O; Huebner M; Herrmann E; Zissler U; Rosewich M; Baer PC; Buhl R; Schmitt-Grohé S; Zielen S; Schubert R
Cytokine; 2010 May; 50(2):152-7. PubMed ID: 20181491
[TBL] [Abstract][Full Text] [Related]
5. [Metalloproteinase-9/tissue inhibitor of metalloproteinase-1 in induced sputum in patients with asthma and chronic obstructive pulmonary disease and their relationship to airway inflammation and airflow limitation].
Xin XF; Zhao M; Li ZL; Song Y; Shi Y
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Mar; 30(3):192-6. PubMed ID: 17572998
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-18 in induced sputum: association with lung function in chronic obstructive pulmonary disease.
Rovina N; Dima E; Gerassimou C; Kollintza A; Gratziou C; Roussos C
Respir Med; 2009 Jul; 103(7):1056-62. PubMed ID: 19208460
[TBL] [Abstract][Full Text] [Related]
7. Profiling of sputum inflammatory mediators in asthma and chronic obstructive pulmonary disease.
Bafadhel M; McCormick M; Saha S; McKenna S; Shelley M; Hargadon B; Mistry V; Reid C; Parker D; Dodson P; Jenkins M; Lloyd A; Rugman P; Newbold P; Brightling CE
Respiration; 2012; 83(1):36-44. PubMed ID: 21912093
[TBL] [Abstract][Full Text] [Related]
8. Leptin as local inflammatory marker in COPD.
Broekhuizen R; Vernooy JH; Schols AM; Dentener MA; Wouters EF
Respir Med; 2005 Jan; 99(1):70-4. PubMed ID: 15672852
[TBL] [Abstract][Full Text] [Related]
9. Quantitation of leukotriene B(4) in human sputum as a biomarker using UPLC-MS/MS.
Jian W; Edom RW; Xue X; Huang MQ; Fourie A; Weng N
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Aug; 932():59-65. PubMed ID: 23831697
[TBL] [Abstract][Full Text] [Related]
10. [Expressions of cyclooxygenase-2 and matrix metalloproteinase-2 and airflow obstruction in patients with chronic obstructive pulmonary disease].
Chen Y; Chen P
Zhonghua Jie He He Hu Xi Za Zhi; 2005 May; 28(5):324-7. PubMed ID: 15949313
[TBL] [Abstract][Full Text] [Related]
11. [The change of concentration of endothelin derived from alveolar macrophages and in induced sputum in patients with chronic bronchitis].
Peng H; Chen P; Cai S
Zhonghua Jie He He Hu Xi Za Zhi; 2001 Jun; 24(6):351-4. PubMed ID: 11802988
[TBL] [Abstract][Full Text] [Related]
12. HOPE-preservation of paraffin-embedded sputum samples--a new way of bioprofiling in COPD.
Pedersen F; Marwitz S; Seehase S; Kirsten AM; Zabel P; Vollmer E; Rabe KF; Magnussen H; Watz H; Goldmann T
Respir Med; 2013 Apr; 107(4):587-95. PubMed ID: 23312618
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA expression in induced sputum of smokers and patients with chronic obstructive pulmonary disease.
Van Pottelberge GR; Mestdagh P; Bracke KR; Thas O; van Durme YM; Joos GF; Vandesompele J; Brusselle GG
Am J Respir Crit Care Med; 2011 Apr; 183(7):898-906. PubMed ID: 21037022
[TBL] [Abstract][Full Text] [Related]
14. Lack of Correlation Between Pulmonary and Systemic Inflammation Markers in Patients with Chronic Obstructive Pulmonary Disease: A Simultaneous, Two-Compartmental Analysis.
Núñez B; Sauleda J; Garcia-Aymerich J; Noguera A; Monsó E; Gómez F; Barreiro E; Marín A; Antó JM; Agusti A;
Arch Bronconeumol; 2016 Jul; 52(7):361-7. PubMed ID: 26921918
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of the novel phosphodiesterase-4 inhibitor BAY 19-8004 on lung function and airway inflammation in asthma and chronic obstructive pulmonary disease (COPD).
Grootendorst DC; Gauw SA; Benschop N; Sterk PJ; Hiemstra PS; Rabe KF
Pulm Pharmacol Ther; 2003; 16(6):341-7. PubMed ID: 14580925
[TBL] [Abstract][Full Text] [Related]
16. 3-Chlorotyrosine in sputum of COPD patients: relationship with airway inflammation.
O'Donnell C; Newbold P; White P; Thong B; Stone H; Stockley RA
COPD; 2010 Dec; 7(6):411-7. PubMed ID: 21166629
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor: an angiogenic factor reflecting airway inflammation in healthy smokers and in patients with bronchitis type of chronic obstructive pulmonary disease?
Rovina N; Papapetropoulos A; Kollintza A; Michailidou M; Simoes DC; Roussos C; Gratziou C
Respir Res; 2007 Jul; 8(1):53. PubMed ID: 17631682
[TBL] [Abstract][Full Text] [Related]
18. Inhalation of LPS induces inflammatory airway responses mimicking characteristics of chronic obstructive pulmonary disease.
Korsgren M; Linden M; Entwistle N; Cook J; Wollmer P; Andersson M; Larsson B; Greiff L
Clin Physiol Funct Imaging; 2012 Jan; 32(1):71-9. PubMed ID: 22152082
[TBL] [Abstract][Full Text] [Related]
19. Expression of interleukin (IL)-10, IL-17A and IL-22 in serum and sputum of stable chronic obstructive pulmonary disease patients.
Zhang L; Cheng Z; Liu W; Wu K
COPD; 2013 Aug; 10(4):459-65. PubMed ID: 23537276
[TBL] [Abstract][Full Text] [Related]
20. Correlation of exhaled nitric oxide with nitrogen oxides and selected cytokines in induced sputum of chronic obstructive pulmonary disease patients.
Ziora D; Dworniczak S; Kaczmarczyk G; Jastrzebski D; Krzywiecki A; Kozielski J
J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 2):791-9. PubMed ID: 18204193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
